Evaluation of primary health care by users during the COVID-19 pandemic: A cross-sectional study.

Evaluation of primary health care by users during the COVID-19 pandemic: A cross-sectional study.

Publication date: Sep 22, 2023

To evaluate the primary health care (PHC) attributes and associated factors during the COVID-19 pandemic using the perspective of users. This cross-sectional, quantitative study included 422 PHC users from 96 Family Health Teams in a city in Brazil. The assessment used the Primary Care Assessment Tool (PCATool) and a structured questionnaire on the sociodemographic and epidemiological characteristics of users and basic health units (BHU). The Person’s chi-square test was used to analyze the association between high overall scores in PCATool and characteristics of users and BHU. Crude and adjusted prevalence ratios (PR) with a 95% confidence interval were also calculated. Poisson regression and Rao Scott’s Chi-square test were used to estimate crude PR. Most users were aged 30 to 39 years (26. 3%), women (75. 4%), registered at the BHU for over ten years (59. 5%), and had incomplete secondary education (30. 6%). The mean of PHC essential attributes and overall scores were low (6. 10 +/- 0. 81 and 5. 78 +/- 0. 77, respectively). “First-contact care-use” received the highest score (9. 22 +/- 1. 62), while “first-contact care-accessibility” received the lowest (2. 82 +/- 0. 90). High overall scores were associated with an average employment time of professionals (doctors and nurses) at the BHU (PR = 1. 31; 95% CI 1. 17-1. 48; p < 0. 001) and lower educational level of users (PR = 1. 71; 95% CI 1. 54-1. 90; p < 0. 001. "First-contact care-use" was the best evaluated, while "first-contact care-accessibility" was the worst. High scores were associated with a lower educational level of users and BHU with more experienced professionals.

Open Access PDF

Concepts Keywords
Brazil Assessment
Education Attributes
Nurses Bhu
Pandemic Care
Years Contact


Type Source Name
disease MESH COVID-19 pandemic
disease MESH Family Health
drug DRUGBANK Pentaerythritol tetranitrate
disease VO time
disease MESH educational level
drug DRUGBANK Ribostamycin
drug DRUGBANK Coenzyme M
drug DRUGBANK Pidolic Acid
drug DRUGBANK Ilex paraguariensis leaf
disease IDO history
disease IDO process
pathway REACTOME Reproduction
disease VO organization
disease MESH emergency
disease IDO country
disease MESH infection
disease VO protocol
disease VO population
drug DRUGBANK Trestolone
disease VO Equity
disease VO effectiveness
drug DRUGBANK Nonoxynol-9
disease VO vaccinated
disease VO vaccination
disease MESH chronic disease
drug DRUGBANK L-Valine
drug DRUGBANK Aspartame
disease VO frequency
disease MESH Hypertension
disease MESH Obesity
disease VO effective
disease MESH infectious diseases
disease VO efficient
disease VO efficiency
drug DRUGBANK Serine
drug DRUGBANK Mitomycin
disease MESH Primary Care Accessibility

Original Article

(Visited 1 times, 1 visits today)